Juvenile diabetes.
That’s what we used to call it.
Forty years ago, and wow, typing that makes me realize how old I am, type 1 diabetes was known as juvenile diabetes. Type 2 diabetes was called adult-onset diabetes. The names …
I Know My A1C. That Should Be Enough.
“I know my A1C.”
Shouldn’t that be enough?
Quick teaching moment. The hemoglobin A1C is a measurement that averages blood sugar levels over the past two to three months. Someone whose pancreas is not on permanent vacation typically has an …
GLP-1s at a Crossroads: Safety, Access, and the Future of Care
When a pharmaceutical giant sues a telehealth company over weight-loss drugs, it sounds like the beginning of a streaming documentary.
But this isn’t entertainment. It’s healthcare, and it’s complex, consequential, and evolving in very visible ways.
The recent lawsuit filed …
PBM Reform and Insulin Pricing: Progress, With Conditions
Every once in a while, a healthcare headline comes along that makes people do a double-take.
“FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients.”
That’s right. Landmark. Lower drug costs. Insulin. Accountability.
Cue the record …
Another Year of Progress and Perspective
As the calendar turns, I find myself thinking less about resolutions and more about reflection. Living and working in diabetes means every year brings new technology, new data, and new promises—but it also brings the same daily realities that don’t …